These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12506731)

  • 1. Control your exposure for costs of injectables, biologics.
    Capitation Rates Data; 2002 Dec; 7(12):137-8. PubMed ID: 12506731
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing the cost drivers of medical injectables.
    Johnson KA
    Manag Care Interface; 2003 Apr; 16(4):37-40. PubMed ID: 12747140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What employers can do about pharmaceutical costs.
    Norton JA
    J Health Care Benefits; 1994; 4(1):4-8. PubMed ID: 10137544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specialty pharmaceuticals: developing a management plan.
    Willcutts D
    Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 6. How well does your PBM perform?
    McCarthy R
    Bus Health; 1999 Jan; 17(1):24-9. PubMed ID: 10345211
    [No Abstract]   [Full Text] [Related]  

  • 7. Your next move in managing drug costs.
    Heenan J
    Bus Health; 1995 Aug; 13(8):31-2, 36, 38. PubMed ID: 10153416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical industry and payer partnerships to manage costs and improve quality.
    Mauch RP
    Manag Care; 2001 Sep; 10(9 Suppl):2-4; discussion 9-12. PubMed ID: 11729438
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic conditions and disabilities: trends and issues for private drug plans.
    Boccuti C; Moon M; Dowling K
    Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797
    [No Abstract]   [Full Text] [Related]  

  • 10. A behind-the-numbers look at rising Rx costs.
    McCarthy R
    Bus Health; 1998 Feb; 16(2):29, 32-5. PubMed ID: 10177023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives. Options vs. limits: drug cost strategies reconsidered.
    Cunningham R
    Faulkner Grays Med Health; 1997 Sep; 51(38):suppl 4. PubMed ID: 10173171
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 13. 4 payer trends to control specialty pharmacy costs.
    Studin I
    Manag Care; 2012 May; 21(5):27-9. PubMed ID: 22670484
    [No Abstract]   [Full Text] [Related]  

  • 14. When success sours: PBMs under scrutiny.
    Carroll J
    Manag Care; 2002 Sep; 11(9):20-6. PubMed ID: 12369344
    [No Abstract]   [Full Text] [Related]  

  • 15. West Virginia's Rx for drug costs: West Virginia's new prescription drug program is being called "the mouse that roared".
    Kent C
    State Legis; 2005 Feb; 32(2):23. PubMed ID: 15704275
    [No Abstract]   [Full Text] [Related]  

  • 16. Supply and demand: negotiating the prescription drug labyrinth to reduce costs.
    DeStefino K
    Benefits Q; 2003; 19(1):30-7. PubMed ID: 12608116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug utilization: using objective data to achieve cost-efficiency.
    Eber BL
    Benefits Q; 2005; 21(1):7-13. PubMed ID: 15825631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does population management of chronic disease lead to lower costs of care?
    Crosson FJ; Madvig P
    Health Aff (Millwood); 2004; 23(6):76-8. PubMed ID: 15537587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining a mission. Medicaid plans focus on pharmaceutical care.
    Gearon CJ
    Healthplan; 2002; 43(4):54-6. PubMed ID: 12221779
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the PBM in total health management strategies for individuals with chronic conditions.
    Slezak J; Stine N
    Benefits Q; 2003; 19(1):38-44. PubMed ID: 12608117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.